Floatz logo

Prednisone

B-Cell Neoplasm

Curis, Inc.Small moleculePhase 2Active
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
89/ 100

Competitive context

47 Active assets in the B-Cell Neoplasm cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
University Hospital, Basel, Switzerland
Phase 2BB
Zanubrutinib
Curis, Inc.
Phase 2BB
Adriamycin
Curis, Inc.
Phase 2BB
Rituximab
Curis, Inc.
Phase 2BB
Lenalidomide
M.D. Anderson Cancer Center
Phase 2B

View all 50 →

Same molecule, other indications

Prednisone is also rated in:

peripheral T-cell lymphoma, not otherwise specifiedActive
BBB
Indicative · Phase 4
74 / 100
View asset →
diffuse large B-cell lymphomaActive
BBB
Indicative · Phase 4
74 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative · Phase 3
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →